Botox has been a leading name in the field of cosmetic medicine for decades, serving as a non-surgical treatment to reduce wrinkles between the brows and along the edges of the eyes. Botox, a neurotoxin, prevents wrinkles by paralyzing the muscles in the face that make you furrow your brow or wrinkle your forehead. However, new brands of neurotoxins are now available, meaning some patients may be unsure of which brand to choose. Here is a closer look at Botox and some leading competitors.
Brands available to patients
Aside from Botox, patients have several options for neurotoxin treatment. The two major FDA-approved brands on the market, Xeomin and Dysport, may not be as widely available as Botox. Xeomin and Botox are injected at the same strength, however Dysport is injected at a different strength. A 2:1 ratio of Dysport to Botox or Xeomin is typically needed for similar results. Still, these botulinum neurotoxins are used for the same purpose; reducing wrinkles.
Notable differences in clinical results
Because Botox has been around much longer than Xeomin and Dysport, it carries the longest FDA approval of the three brands. Xeomin uses the same toxin as Botox, but it has the least amount of protein surrounding the botulinum molecule. This means that there is theoretically a lower chance of immunity to the toxin. Dysport had the highest chance of complications for patients, with a larger chance of localized migration away from the injection site.
Botox, Xeomin and Dysport are all recommended with the lowest dose possible for optimal results, and they each produce very similar results in patients. Therefore, patients should consider safety concerns like those discussed above as they determine which therapy is right for their needs.
If you are considering Botox treatment, Dr. Sami Bittar can provide you with the detailed care you need to see beautiful, natural-looking results. To schedule your first consultation at Dr. Bittar’s La Grange practice, call 708-354-4667.